Today's top medical abstracts
Rheumatology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?

Home
General Rheumatology
For Practicing
Rheumatologists
Conferences
Jobs
Newsletters
My Library
Topics in
Rheumatology
        Amyloidosis
        Autoimmune/Heritable
        Basic Science/Genetics
        Bone Metabolism
        Chr Fatigue/Fibromyalgia
        Clinical Pharmacology
        Connective Tissue Dz
        Diagnostics/Radiology
        Economics of Medicine
        Gout and Hyperuricemia
        Infectious Arthritis
        Osteoarthritis
        Other Arthritis
        Pediatric Rheumatology
        Popular Press
        Rheumatoid Arthritis
        Spondylarthropathies
        Systemic Lupus (SLE)
        Vasculitic Syndromes
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor
For Practicing Rheumatologists
Today's Rheumatology News: Reclast Effective And Preferred By Patients
D Scott Cunningham MD, PhD, MDLinx Rheumatology
Today's Rheumatology News: Birthweight Linked To RA
D Scott Cunningham MD, PhD, MDLinx Rheumatology
  See all
systemic sclerosis;autologous stem cell transplantation Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website
Autologous stem cell transplantation improves microcirculation in systemic sclerosis
Annals of Rheumatic Diseases, 05/16/08
Print     Email This Article     Save in My Library   Free Abstract
Miniati I et al. – Autologous Hemopoietic Stem Cells Transplantation (HSCT) with high dose cyclophosphamide (CYC) regimen may foster vascular remodelling while CYC at lower doses and with a chronic regimen does not influence the microvasculature.

Methods
  • A study to evaluate the improvement of microvasculature after HSCT severe diffuse cutaneous systemic sclerosis (dcSSc) pts
  • 16 severe dcSSc pts, with a "late" videocapillaroscopy pattern underwent an immunesuppressive treatment
  • 6 were treated with HSCT and 10 with monthly pulse of CYC 1 g for 6 mos and then orally with 50 mg/day for further 6 mos
  • Nailfold videocapillaroscopy (NVC) was performed before and after 3 mos from the beginning of each treatment and then repeated every 3 mos

Results
  • In all pts, before HSCT, NVC large avascular areas and ramified capillaries and vascular architectural disorganization ("late" pattern) was noted
  • 3 mos after HSCT, NVC pattern changed from "late" into "active", showing frequent giant capillaries (>6/mm) and haemorrhages, absence of avascular areas and angiogenesis phenomena
  • After 1 year from HSCT, microvascular abnormalities were still in the "active" pattern
  • In pts treated with CYC, no NVC modifications were observed during 24 mos of f/u and the pattern remained always "late”

 

Sponsor
--- CONNECTIVE TISSUE DZ TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email



Sponsor
Read a Different Specialty
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology
Profession Index
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2008 MDLinx, Inc.